Akoya Biosciences has announced a public offering of its common stock, but the terms have not been disclosed yet. This may create uncertainty among investors, leading to a neutral short-term impact on the stock price. The stock price could be affected once the terms are disclosed and investors have a clearer understanding of the offering.